InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the detailed record of transactions filed by Mitchener Stephen, Directeur Exécutif. Director active across 1 companies, notably Karyopharm Therapeutics Inc.. Aggregated, 7 filings have been logged. Total volume traded: €14k. The latest transaction was filed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
047,250 shares0
Common Stock
SEC:0001209191-22-014623:0·
€2,949499 shares@ €5.91010.0017% mcap42.3% of flow
Common Stock
SEC:0001209191-21-067954·
€2,949499 shares@ €5.91010.0017% mcap21.2% of flow
Common Stock
SEC:0001209191-21-067954:0·
€4,017528 shares@ €7.60860.0023% mcap57.7% of flow
Common Stock
SEC:0000899243-21-021767·
€4,017528 shares@ €7.60860.0023% mcap28.8% of flow
Common Stock
SEC:0000899243-21-021767:0·
1,500 shares
Common Stock
SEC:0000899243-21-021292·
1,500 shares
Common Stock
SEC:0000899243-21-021292:0·
7 of 7 declarations
About Mitchener Stephen
Mitchener Stephen serves as Executive Vice President and Chief Business Officer at Karyopharm Therapeutics Inc. In this role, he is responsible for business strategy and managing operations. His expertise in the biopharmaceutical sector is essential in supporting growth and innovation.
